Skip to content

Drug interactions

Crizotinib + Pexidartinib

Severity: Major

Crizotinib and Pexidartinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pexidartinib is a CYP3A4 substrate, and crizotinib may raise its exposure. Pexidartinib carries a serious hepatotoxicity risk that could be worsened, and crizotinib itself can cause liver injury.

What this interaction means in plain words

Crizotinib and Pexidartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Pexidartinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Crizotinib inhibits CYP3A4 metabolism of pexidartinib, with overlapping hepatotoxicity.

What to do

Avoid if possible. If used, reduce pexidartinib dose per labeling and monitor liver tests closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Pexidartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Pexidartinib?

MediHelp rates the interaction as major. Crizotinib and Pexidartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pexidartinib is a CYP3A4 substrate, and crizotinib may raise its exposure. Pexidartinib carries a serious hepatotoxicity risk that could be worsened, and crizotinib itself can cause liver injury.

How serious is the interaction between Crizotinib and Pexidartinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If used, reduce pexidartinib dose per labeling and monitor liver tests closely.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in